Russell Investments Group
DMAC icon

Russell Investments Group’s DiaMedica Therapeutics DMAC Stock Holding History

Russell Investments Group’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.5K Buy
9,168
+6,497
+243% +$39.9K ﹤0.01% 3564
2026
Q1 		$18.1K Hold
2,671
– – ﹤0.01% 3651
2025
Q4 		$21.3K Sell
2,671
-1,250
-32% -$9.35K ﹤0.01% 3610
2025
Q3 		$26.9K Buy
+3,921
New +$21.3K ﹤0.01% 3508

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Russell Investments Group's DMAC Position: Q2 2026 in Review

Russell Investments Group increased its DiaMedica Therapeutics (DMAC) stake by 243% in Q2 2026, buying an estimated $39.9K and bringing the position to 9,168 shares worth $64.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3564.

Russell Investments Group first reported a position in DMAC in Q3 2025 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Russell Investments Group held 9,168 shares of DiaMedica Therapeutics worth $64.5K as of Q2 2026.
  • Russell Investments Group bought 6,497 DiaMedica Therapeutics shares in Q2 2026, an estimated $39.9K.
  • DiaMedica Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3564 holding.
  • Russell Investments Group first reported a position in DiaMedica Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.